Where does Dexcom, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dexcom, Inc. ranks #628 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dexcom, Inc. hold?

Dexcom, Inc. holds 708 US utility patents granted between 2015 and 2025, spanning 53 technology areas.

What is Dexcom, Inc.'s Innovation Score?

Dexcom, Inc. has an Innovation Score of 65.3 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dexcom, Inc. focus on?

Dexcom, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 636 patents. Grants appear in 53 CPC subclasses total.

Is Dexcom, Inc.'s patent grant rate increasing or decreasing?

Dexcom, Inc.'s recent grant velocity is +26% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Dexcom, Inc.'s patents?

Dexcom, Inc.'s patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dexcom, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dexcom, Inc.

USPTO PatentsView assignee record - 708 granted patents across 53 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dexcom ranks #628 of 49,997 tracked US assignees by granted-patent volume, with 708 patents across 53 technology areas.

#628
of 49,997 US assignees by volume: Top 1%
by Innovation Score (65.3/100): 19.3
avg claims per patent: +26%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R628 · US Corporation #628 · 708 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 708 grants
TOP-DECILE #628/49,997
PHOTO-FINISH Allegro MicroSystems
CPC-WIDE A61B · 53 areas
INNOV-STRONG 65.3/100
CLAIMS-RICH 19.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +26% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Allegro MicroSystems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Imagination · near

65
Dexcom · this assignee

65
Airbus Operations SAS · near

65
University of… · near

65
Deka Products… · near

65
3D Lighting… · lowest

7

What this shows Dexcom's Innovation Score is 65.3/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Dexcom's grant cadence moved

Between 2020–2024, Dexcom, Inc. received 362 grants versus 287 in 2015–2019 (+26% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 81 grants and bottomed in 2015 at 35. Lead class A61B accounts for 89.8% of the portfolio across 53 subclasses. Volume neighbours: Viavi Solutions Inc. (#624) and Toppan Printing Co., Ltd. (#632).

Dexcom's three-year grant acceleration

From 2019–2021 to 2022–2024, Dexcom, Inc. moved from 226 to 204 grants (0.90x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,461. See the growth leaderboard.

Viavi Solutions

710
CJ Cheiljedang

709
NEW York Universi…

709
Allegro Microsyst…

708
Krones

708
Dexcom ◀

708
Arista Networks

706
DOW Agrosciences

704
Toppan Printing

704

What this shows Dexcom holds 708 patents at rank #628, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dexcom

By rank, the assignees closest to #628 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Dexcom's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Dexcom, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (65 here).

University of Washington 65 Airbus Operations SAS 65 Deka Products Limited Parternship 65 Imagination Technologies Limited 65

Similar claim depth

Nearest assignees by average claims per patent (19.3 here).

AT&T Intellectual Property I, L.P. 19.3 avg Grote Industries, Inc. 19.3 avg Maxlinear Asia Singapore PTE Ltd 19.3 avg Amkor Technology, Inc. 19.3 avg

Dexcom's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Dexcom, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	35	4.9%
2016	47	6.6%
2017	79	11.2%
2018	58	8.2%
2019	68	9.6%
2020	81	11.4%
2021	77	10.9%
2022	62	8.8%
2023	64	9.0%
2024	78	11.0%
2025partial year	59	8.3%

Which technologies does Dexcom, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 636

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 333

Y02A - Technologies FOR Adaptation TO Climate Change 263

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 167

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 111

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 99

H04W - Wireless Communication Networks 94

G06F - Electric Digital Data Processing 79

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 62

H04Q - Selecting 46

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 43

G06T - Image Data Processing OR Generation, IN General 37

H04B - Transmission 36

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 34

H04M - Telephonic Communication 29

Top 15 of 53 technology areas

Where it ranks

Overall rank by patents

#628

of 49,997 tracked assignees

Innovation Score

65.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Dexcom, Inc.'s patent record in context - here's where to go next.

Dexcom, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 89.8% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #628 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dexcom, Inc. against Viavi Solutions Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 65.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.